Financiere Arbevel is an investment management firm that provides financial and asset management services.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Financiere Arbevel is an investment management firm that provides financial and asset management services.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2022 | Eovolt | Venture Round | 16.2M |
9/2020 | keepMED | Series C | 0 |
12/2022 | Kalray | Venture Round | 0 |
4/2021 | Adwanted Group | Series A | 17.6M |
2/2020 | Scipio Bioscience | Series A | 6.5M |
4/2021 | UroMems | Series B | 8.3M |
5/2020 | UroMems | Series B | 17.6M |
1/2021 | Corwave | Series C | 43.2M |
6/2019 | TransCure bioServices | Venture Round | 2.8M |
4/2019 | NH TherAguix | Series A | 14.6M |
5/2021 | MEXBRAIN | Series A | 6.9M |
3/2021 | Pledg | Debt Financing | 0 |
5/2022 | Germitec SAS | Venture Round | 0 |
3/2021 | Pledg | Venture Round | 0 |
5/2022 | Germitec SAS | Venture Round | 0 |
5/2021 | MEXBRAIN | Series A | 0 |
4/2021 | UroMems | Series B | 0 |
4/2021 | Adwanted Group | Series A | 0 |
3/2021 | Pledg | Venture Round | 0 |
3/2021 | Pledg | Debt Financing | 0 |
1/2021 | Corwave | Series C | 0 |
9/2020 | keepMED | Series C | 0 |
5/2020 | UroMems | Series B | 0 |
2/2020 | Scipio Bioscience | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|